CBN209350
CBN209350 is a selective KDM4 inhibitor with an IC50 of 4 μM. CBN209350 exerts antiproliferative effects on prostate cancer cells. CBN209350 can be used for the research of prostate cancer.
For research use only. We do not sell to patients.
- CAS No.: 726201-10-1
- Formula: C13H12N4O3
- Molecular Weight:272.26
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
CBN209350 exerts inhibitory effects with comparable potency against all tested KDM4 family subtypes, and exhibits moderate selectivity for KDM4 over KDM2A (IC50 120 μM) and PHF8 (IC50 30 μM)[1].
CBN209350 (48 h) exerts cytostatic effects on LnCaP prostate cancer cells[1].
CBN209350 (100 μM; 48 h) reduces the level of H3K9me3 in PC-3 prostate cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human prostate cancer cell lines LnCaP, DU145, PC-3
-
Concentration:Dose-response titration
-
Incubation Time:48 h
-
Result:Inhibited LnCaP cell viability with an IC50 of 410 μM.
Did not reduce DU145 or PC-3 cell viability by 50% at concentrations up to 1000 μM (IC50 >1000 μM for both cell lines).
-
Cell Line:Human prostate cancer cell lines LnCaP, DU145, PC-3
-
Concentration:100 μM
-
Incubation Time:48 h
-
Result:Did not alter global H3K9me3 levels relative to DMSO-treated control in LnCaP or DU145 cells.
Caused a significant decrease in global H3K9me3 levels relative to DMSO-treated control in PC-3 cells.
Chemical Information
-
CAS No. 726201-10-1
-
Molecular Weight 272.26
-
Formula C13H12N4O3
-
SMILES
O=C(OC)CC1=NN(C(=O)C1)C2=NC=3C=CC=CC3N2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)